Dec 272017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors elected veteran biotechnology executive William Waddill as an independent director of the company, with a term beginning effective January 1, 2018.… => Read Full post

Arrowhead Pharmaceuticals appoints Will Waddill to its Board as Independent Director

From:: Arrowhead Pharmaceuticals appoints Will Waddill to its Board as Independent Director

Sorry, the comment form is closed at this time.

%d bloggers like this: